{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:27:31Z","timestamp":1768634851037,"version":"3.49.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.critrevonc.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T19:15:14Z","timestamp":1474571714000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["An overview of hematopoietic stem cell transplantation related thrombotic complications"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-0068","authenticated-orcid":false,"given":"Ugur","family":"Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Ataca Atilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erden","family":"Atilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selami Kocak","family":"Toprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Demirer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2016.09.004_bib0005","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.bbmt.2008.11.036","article-title":"Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience","volume":"15","author":"Aglietta","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0010","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"19","author":"Arai","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0015","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/07357907.2014.919301","article-title":"Complications of allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Arnaout","year":"2014","journal-title":"Cancer Invest."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0020","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0025","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bmt.1702386","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation","volume":"25","author":"Azoulay","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0030","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: a question of attribution","volume":"143","author":"Bagot","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0035","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/annonc\/mdl086","article-title":"Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe","volume":"17","author":"Barkholt","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0040","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa053583","article-title":"Thalidomide and hematopoietic-cell transplantation for multiple myeloma","volume":"354","author":"Barlogie","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0045","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0140-6736(09)60220-8","article-title":"Management of occlusion and thrombosis associated with long-term indwelling central venous catheters","volume":"374","author":"Baskin","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0050","first-page":"527","article-title":"Syngeneic marrow transplantation in patients with multiple myeloma","volume":"18","author":"Bensinger","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0055","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1200\/JCO.2010.32.5936","article-title":"High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials","volume":"29","author":"Berry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0060","first-page":"131","article-title":"High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells","volume":"18","author":"Brunvand","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0065","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0070","first-page":"3599","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0075","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1034\/j.1600-0609.2000.9r200.x","article-title":"Veno-occlusive disease of the liver after hemopoietic cell transplantation","volume":"64","author":"Carreras","year":"2000","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0080","series-title":"EBMT-ESH Handbook on Haematopoietic Stem Cell Transplantation","first-page":"176","article-title":"Early complications after HSCT","author":"Carreras","year":"2012"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0085","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation","volume":"168","author":"Carreras","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.09.004_bib0090","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/bmt.2015.308","article-title":"Venous thromboembolism in hematopoietic stem cell transplant recipients","volume":"51","author":"Chaturvedi","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0095","first-page":"670","article-title":"Incidence of Factor V Leiden and prothrombin G20210A in patients submitted to stem cell transplantation","volume":"85","author":"Chiusolo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0100","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0105","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","article-title":"Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment","volume":"69","author":"Choi","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0110","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0115","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0120","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0125","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/sj.bjc.6602724","article-title":"Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours","volume":"93","author":"De Giorgi","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0130","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/annonc\/mdi017","article-title":"Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience","volume":"16","author":"De Giorgi","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0135","first-page":"907","article-title":"Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation","volume":"15","author":"Demirer","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0140","first-page":"29","article-title":"Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia","volume":"18","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0145","first-page":"491","article-title":"Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels","volume":"17","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0150","first-page":"341","article-title":"Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels","volume":"17","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0155","first-page":"769","article-title":"High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer","volume":"17","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0160","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.bmt.1701902","article-title":"Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation","volume":"24","author":"Demirer","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0165","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ncponc1104","article-title":"Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors","volume":"5","author":"Demirer","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0170","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0175","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1076029615598221","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"22","author":"Elsallabi","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0180","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/j.1538-7836.2008.03077.x","article-title":"Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation","volume":"6","author":"Gonsalves","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0185","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bmt.1701172","article-title":"Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy","volume":"21","author":"Goringe","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0190","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/annonc\/mdh142","article-title":"Hematopoetic stem cell transplantation for solid tumors in Europe","volume":"15","author":"Gratwohl","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0195","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0200","unstructured":"Inc. AP. Soliris\u00ae Package Insert, 2007."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0205","first-page":"5","article-title":"Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukaemia","volume":"55","author":"Jacobs","year":"1979","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0210","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0215","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0220","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0225","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0230","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0235","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/ajcn\/72.1.181","article-title":"Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients","volume":"72","author":"Jonas","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0245","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.clinthera.2007.11.015","article-title":"Meta-analysis of venous thromboembolism prophylaxis in medically III patients","volume":"29","author":"Kanaan","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0250","doi-asserted-by":"publisher","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0255","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40261-014-0242-x","article-title":"Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation","volume":"34","author":"Keating","year":"2014","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0260","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/trf.12859","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options","volume":"55","author":"Kim","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0265","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.bmt.1704291","article-title":"Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients","volume":"32","author":"Kroger","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0270","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4065\/78.5.589","article-title":"Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation","volume":"78","author":"Kumar","year":"2003","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl. (2)","key":"10.1016\/j.critrevonc.2016.09.004_bib0275","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1038\/bmt.2008.69","article-title":"28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures","volume":"41","author":"Ladenstein","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0280","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0285","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","article-title":"Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"96","author":"Laskin","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0290","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.20512","article-title":"Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients","volume":"81","author":"Magagnoli","year":"2006","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0295","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.bmt.1705241","article-title":"Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy","volume":"37","author":"Mateos","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0300","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMoa1114083","article-title":"Lenalidomide after stem-cell transplantation for multiple myeloma","volume":"366","author":"McCarthy","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0305","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0310","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0889-8588(05)70348-8","article-title":"Thrombotic microangiopathies associated with drugs and bone marrow transplantation","volume":"10","author":"Moake","year":"1996","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0315","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bmt.1705657","article-title":"Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient","volume":"39","author":"Ostronoff","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0320","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1700760","article-title":"Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation","volume":"19","author":"Park","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0325","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/cncr.21477","article-title":"Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation","volume":"104","author":"Peccatori","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0330","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/sj.bmt.1704153","article-title":"Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) registry 1990\u20131999","volume":"32","author":"Pedrazzoli","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0335","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/annonc\/mdl044","article-title":"High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults","volume":"17","author":"Pedrazzoli","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0340","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","article-title":"Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients","volume":"74","author":"Pihusch","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0345","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/01.TP.0000136988.38919.FB","article-title":"Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation","volume":"78","author":"Pihusch","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0350","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(09)60178-1","article-title":"Prophylaxis of catheter-related thrombosis in cancer patients","volume":"373","author":"Prandoni","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0355","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.bmt.1705528","article-title":"Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)","volume":"38","author":"Ramasamy","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0360","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40264-013-0054-6","article-title":"Drug-induced thrombosis: an update","volume":"36","author":"Ramot","year":"2013","journal-title":"Drug Saf."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0365","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000046590","article-title":"Hepatic veno-occlusive disease following hematopoietic stem cell transplantation","volume":"106","author":"Richardson","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0370","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0375","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1182\/blood-2008-12-196238","volume":"114","author":"Richardson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0380","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0385","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/sj.bmt.1702387","article-title":"N-Acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation","volume":"25","author":"Ringden","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0390","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1111\/j.1538-7836.2005.01398.x","article-title":"Deep vein thrombosis associated with central venous catheters \u2013 a review","volume":"3","author":"Rooden","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0395","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0400","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0405","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3324\/haematol.10521","article-title":"Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Secondino","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0410","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1160\/TH09-10-0700","article-title":"Leukocyte count and risk of thrombosis in patients undergoing haematopoietic stem cell transplantation or intensive chemotherapy","volume":"103","author":"Stoffel","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0415","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.beha.2008.12.002","article-title":"Thrombotic complications after haematopoietic stem cell transplantation: early and late effects","volume":"22","author":"Tsakiris","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0420","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bbmt.2014.04.030","article-title":"Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Ueda","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0425","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/1744-9987.12015","article-title":"Plasmapheresis-refractory transplantation-associated thrombotic microangiopathy successfully treated with pravastatin and limaprost alfadex","volume":"17","author":"Uesawa","year":"2013","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0430","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1200\/JCO.2005.05.002","article-title":"Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study","volume":"23","author":"van Rooden","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0435","first-page":"201","article-title":"The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis","volume":"89","author":"Van Rooden","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0440","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11739-008-0125-3","article-title":"Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients","volume":"3","author":"Verso","year":"2008","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0445","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","article-title":"Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment","volume":"10","author":"Wadleigh","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0450","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","article-title":"ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy","volume":"36","author":"Worel","year":"2007","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0455","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1182\/blood-2011-08-375816","article-title":"Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome)","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0460","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0140-6736(09)60205-1","article-title":"Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial","volume":"373","author":"Young","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.09.004_bib0465","first-page":"247","article-title":"Bone marrow transplant-associated thrombotic microangiopathy: a case series","volume":"15","author":"Zeigler","year":"1995","journal-title":"Bone Marrow Transplant."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816302293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816302293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T06:08:00Z","timestamp":1601100480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842816302293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":93,"alternative-id":["S1040842816302293"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.09.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of hematopoietic stem cell transplantation related thrombotic complications","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}